Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Ana M. Ciurea Image

      Ana M. Ciurea, M.D.

      Department of Dermatology, Division of Internal Medicine

      Present Title & Affiliation

      Primary Appointment

      Professor, Dermatology, Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Associate Professor, Dermatology, Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Assistant Professor, Dermatology, Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Research Interests

      Malignant melanoma

      Cutaneous toxicities related to various chemotherapeutic agents

      Cutaneous infectious diseases

      Education & Training

      Degree-Granting Education

      1996University of Medicine and Pharmaceuticals, Iasi, RO, MD

      Postgraduate Training

      2007-2008Chief Resident, Dermatology, Northwestern University, Chicago, Illinois
      2005-2008Resident, Dermatology, Northwestern University, Chicago, Illinois
      2004-2005Research Fellowship, Dermatology, Northwestern University, Chicago, Illinois
      2003-2004Chief Resident, Internal Medicine, Penn State University (Pinnacle Health Hospital), Harrisburg, Pennsylvania
      2001-2004Resident, Internal Medicine, Penn State University (Pinnacle Health Hospital), Harrisburg, Pennsylvania
      1997-2000Resident, Pediatrics, St. Maria University Hospital, Iasi

      Licenses & Certifications

      2024Basic Life Support
      2008Texas Medical Board
      2008American Board of Dermatology
      2008DEA
      2004American Board of Internal Medicine

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2019

      Assistant Professor, Dermatology, Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2008 - 2013

      Administrative Appointments/Responsibilities

      Project Director of Dermatology, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2014 - Present

      Associate Medical Director, Cancer Prevention Clinic, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - Present

      Other Professional Positions

      Visiting Professor, Gr. T. Popa University of Medicine and Pharmacy, Iasi, 2017 - Present

      Extramural Institutional Committee Activities

      Member, Dermatopathology Faculty Search Commitee, The University of Texas MD Anderson Cancer Center, 2023 - 2024

      Member, Dermatology Department Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2024

      Patient Care Committee, Faculty Excellence Awards Review Board, The University of Texas MD Anderson Cancer Center, 2018 - 2018

      Research Grants Programs, Study Section Review Committee for Clinical Translational and Population-Based Research Projects, The University of Texas MD Anderson Cancer Center, 2011 - 2014

      Member, Institutional Review Board 5, The University of Texas MD Anderson Cancer Center, 2011 - 2012

      Editorial Activities

      Editor, Nature Research, 2019 - 2020

      Reviewer, Archives of clinical cases, 2016 - 2017

      Reviewer, Journal of Immunotherapy, 2015 - 2016

      Honors & Awards

      2024 - PresentTop performer 1%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems
      2023Faculty Honoree, Community Outreach
      2023Top Performer 1%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems
      2022Top Performer 1%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems
      2020Top Performer 10%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems
      2019Top Performer 1%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems
      2018Top Performer 10%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems
      2017Top performer 1%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems
      2007Women's Dermatologic Society Mentorship Award
      2006Society of Investigative Dermatology Resident Retreat for Future Academicians Award
      2004Internal Medicine Resident of the Year Award
      2003Best Scientific paper in Clinical Research, Third Virtual Congress of Cardiology, Argentina
      1994First prize 4th year Annual Scientific Symposium, Iasi
      1993Third prize 3rd year Annual Scientific Student Symposium, Iasi
      1990 - 1996Graduated in the top 5% of class
      1990 - 1996National Merit Scholarship during Medical School

      Professional Memberships

      American Medical Association

      2010 - Present

      Houston Dermatological Society

      2010 - Present

      American Academy of Dermatology

      2005 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2021. The Good, The Bad and the Ugly. Conference. MD Anderson Cancer Center. Houston, TX, US.
      2. 2021. Boards Kodachromes. Conference. MDACC. Houston, TX, US.
      3. 2021. Pearls from Inpatient Dermatology- Board Kodachomes. Conference. MDACC. Houston, TX, US.
      4. 2021. Boards Kodachromes. Conference. MDACC. Houston, TX, US.
      5. 2019. Infectious disease mimickers in cancer patients. Conference. Texas Dermatological Society. Houston, TX, US.
      6. 2017. Melanoma prevention, screening and diagnosis. Conference. MD Anderson Cancer Center. Houston, TX, US.
      7. 2017. Understanding melanoma from prevention to cure. Conference. MD Anderson Cancer Center. Houston, TX, US.
      8. 2016. Melanoma prevention, screening and diagnosis. Conference. MD Anderson Cancer Center. Houston, TX, US.
      9. 2015. Melanoma in the modern millennium: a dermatologist perspective. Conference. MD Anderson Cancer Center. Houston, TX, US.
      10. 2015. Melanoma prevention, screening and diagnosis. Conference. MD Anderson Cancer Center. Houston, TX, US.
      11. 2011. Mimickers of Infectious Diseases in Cancer Patients. Conference. Division of Internal Medicine Grand Rounds. Houston, TX, US.
      12. 2011. Introduction to Dermoscopy. Conference. Melanoma Oncology Grand Rounds. Houston, TX, US.

      Regional Presentations

      1. 2019. Panel member. Conference. MD Anderson Cancer Center. Breckenridge, CO, US.
      2. 2017. Panel member. Conference. MD Anderson Cancer Center. Steamboat, CO, US.
      3. 2016. Panel Member. Conference. MD Anderson Cancer Center. Steamboat, CO, US.
      4. 2007. Atypical Mycobacterial Infection an AIDS patient. Conference. Dermatological Society Meeting. Chicago, IL, US.
      5. 2007. An unusual indolent presentation of intravascular B-cell lymphoma in an elderly female. Conference. American Society of Dermatopathology. Chicago, IL, US.
      6. 2007. Metastatic malignant melanoma. Conference. Dermatological Society Meeting, Northwest University. Chicago, IL, US.
      7. 2007. A typical mycobacterium infection in an AIDS patient". Conference. Chicago Dermatological Society Meeting, Northwestern University. Chicago, IL, US.
      8. 2007. Malignant pyoderma. Conference. AAD Meeting. Washington, DC, US.
      9. 2006. Malignant Pyoderma. Conference. Dermatological Society Meeting. Chicago, IL, US.
      10. 2006. Estrogen and skin. Conference. Northwestern University. Chicago, IL, US.
      11. 2006. Malignant pyoderma. Conference. Chicago Dermatological Society. Chicago, IL, US.
      12. 2006. Malignant pyoderma. Conference. Residents Research Forum. St. Louis, MO, US.
      13. 2006. Intravascular B-cell lymphoma. Conference. Chicago Dermatological Society. Chicago, IL, US.
      14. 2005. Pancreatic Panniculitis as First Sign of Pancreatic Carcinoma. Conference. Dermatological Society Meeting Northwestern University. Chicago, IL, US.
      15. 2005. Clinical and Histological Response of Early CTCL to Low-Dose Combination Therapy with Bexarotene and Psoralen Plus Ultraviolet A (PUVA). Conference. American Academy of Dermatology. New Orleans, LA, US.
      16. 2003. Do Doctors Make the Switch: Change in Antibiotic Therapy Based on Blood Culture Results. Conference. American Society of Microbiology. Washington, DC, US.
      17. 2003. Do Doctors Make the Switch: Change in Antibiotic Therapy Based on Blood Culture Results. Conference. Medical Education Day. Harrisburg, PA, US.
      18. 2002. A patient with Mycobacterium Kansasii Infection. Conference. Morbidity and Mortality Conference. Harrisburg, PA, US.

      National Presentations

      1. 2026. Immunotherapy fand Oncolytic Therapy or Advanced Non-Melanoma Skin Cancer, Panel Member. Panelist. 22nd Oncology Updates: Advanced and Controversies. Houston, Texas, US.
      2. 2025. Immunotherapy for Advanced Non-Melanoma Skin Cancer, Panel Member. Panelist. 21ST Oncology Updates: Advances and Controversies. Houston, Texas, US.
      3. 2020. Melanoma session, Panel Member. Invited. 18th Updated: Advances & Controversies. Steamboat, CO, US.
      4. 2019. Cutaneous side effects of targeted therapy and immunotherapy. Invited. Updates in Oncology. Iasi, US.
      5. 2019. Mimickers in dermoscopy. Invited. American Academy of Dermatology. Washington, DC, US.
      6. 2018. Mimickers in dermoscopy. Invited. American Academy of Dermatology. San Diego, CA, US.
      7. 2017. Project DERM: Skin cancer health education: Screening services and outcomes in an underserved population in Harris County, TX. Conference. CPRIT. Austin, TX, US.
      8. 2017. Mimickers in dermoscopy. Invited. American Academy of Dermatology. Orlando, FL, US.
      9. 2017. Project DERM: Skin cancer health education: Screening services and outcomes in an underserved population in Harris County, TX. Invited. American Academy of Dermatology. Orlando, FL, US.
      10. 2014. Infectious disease mimickers in cancer patients, Infectious diseases course. Conference. American Academy of Dermatology. Denver, CO, US.
      11. 2013. Infectious disease mimickers in cancer patients, Infectious diseases course. Invited. American Academy of Dermatology. Miami, FL, US.
      12. 2012. Dermoscopy of non-melanocytic skin lesions. Invited. American Academy of Dermatology Summer Meeting. Boston, MA, US.
      13. 2011. Dermoscopy Workshop. Invited. American Academy of Dermatology. New York, NY, US.
      14. 2011. Merkel cell polymoviurs DNA detection in a patient with Merkel Cell carcinoma and multiple other skin cancers. Invited. American Academy of Dermatology. New Orleans, LA, US.
      15. 2011. In Situ Photoimmunotherapy: A Tumor-Directed Approach to the Treatment of Advanced Melanoma with Cutaneous Metastases. Conference. In Situ Photoimmunotherapy: A Tumor-Directed Approach to the Treatment of Advanced Melanoma with Cutaneous Metastases. ISIP.
      16. 2010. High resolution, high magnification capillary video microscopy imaging as a useful adjunct in the assessment of pharmacological intervention (Tadalafil) for secondary Raynaud's phenomenon due to scleroderma and mixed connective tissue disease. Conference. American Academy of Dermatology. Miami, FL, US.
      17. 2007. Atypical Mycobacterial Infection in an AIDS patient. Conference. Dermatological Society Meeting. Chicago, IL, US.
      18. 2007. Metastatic Melanoma-An Unusual Presentation. Conference. Dermatological Society Meeting. Chicago, IL, US.
      19. 2007. Malignant Pyoderma. Conference. AA Meeting. Washington, DC, US.
      20. 2006. Estrogens and Skin. Conference. Grand Rounds Lecture. Chicago, IL, US.
      21. 2006. Intravascular B-cell Lymphoma. Conference. Dermatological Society. Chicago, IL, US.
      22. 2006. Malignant Pyoderma. Conference. Dermatological Society Meeting. Chicago, IL, US.
      23. 2006. Malignant Pyoderma. Conference. Residents Research Forum. St. Louis, MO, US.
      24. 2005. Pancreatic Panniculitis as First Sign of Pancreatic Carcinoma. Conference. Residents Research Form. Chicago, IL, US.
      25. 2005. Clinical and Histological Response of Early CTCL to Low-Dose Combination Therapy with Bexarotene and Psoralen Plus Ultraviolet A (PUVA). Conference. American Academy of Dermatology. New Orleans, LA, US.
      26. 2003. Do Doctors Make the Switch: Change in Antibiotic Based on Blood Culture Results. Conference. American Society of Microbiology. Washington, DC, US.
      27. 2003. Do Doctors Make the Switch: Change in Antibiotic Therapy Based on Blood Culture Results. Conference. Do Doctors Make the Switch: Change in Antibiotic Therapy Based on Blood Culture Results. Harrisburg, PA, US.
      28. 2002. A Patient with Mycobacterium Kansasii Infection. Conference. Morbidity and Mortality Conference. Harrisburg, PA, US.
      29. 2002. Preoperative Antimicrobial Prophylaxis Administration at Pinnacle Health: How Are We Doing. Conference. Medical Education Day. Harrisburg, PA, US.

      International Presentations

      1. 2025. Overview of the Most Recent Advances in Immunotherapy. Invited. XLIV Symposium of the International Society of Dermatopathology Derm Path 2025. Cape Town, ZA.
      2. 2024. Updates in Dermatologic Care For Melanoma Patient. Invited. Dermatology Conference Zilele "GH. NASTASE". Lasi, RO.
      3. 2021. Skin Cancer Prevention and Screening. Invited. The Conferences of Regional Institute of Oncology Iasi. Iasi, RO.
      4. 2021. Infectious Diseases in Cancer Patients. Invited. “Zilele Gh. Nastate” Dermatology Conference. Iasi, RO.
      5. 2021. The Good, The Bad and the Ugly. Invited. International Society of Dermatopathology, US.
      6. 2020. Advanced Melanoma – Skin Toxicity of Immunotherapy and Targeted Therapy. Invited. Dermatology Conference, “Zilele Gh. Nastase”. Iasi, RO.
      7. 2020. Clinical Pearls – Inpatient Dermatology. Invited. Dermatology Conference, “Zilele Gh. Nastase. Iasi, RO.
      8. 2019. Skin Cancer Prevention and Screening in the Modern Millenniumn. Invited. International Society of Dermatopathlogy. Lisbon, PT.
      9. 2019. Cancer prevention in the modern millennium. Conference. International Society of Dermatopathology. Lisbon, PT.
      10. 2019. Cancer targeted therapy and immunotherapy - skin toxicities. Invited. Gr. T Popa University of Medicine and Pharmacy. Iasi, RO.
      11. 2018. Melanoma treatment - a dermatologist perspective. Conference. Romanian National Oncology Institute. Iasi, RO.
      12. 2018. Melanoma prevention and screening. Invited. Romanian National Oncology Institute. Iasi, RO.
      13. 2017. Challenging melanocytic lesions. Invited. Gr. T Popa University of Medicine and Pharmacy. Iasi, RO.
      14. 2016. Images in dermatology – Lessons learned from great cases. Invited. Gr. T Popa University of Medicine and Pharmacy. Iasi, RO.
      15. 2015. Infectious disease mimickers in cancer patients. Invited. Gr T Popa University of Medicine and Pharmacy. Iasi, RO.
      16. 2015. Treatment of basal cell carcinoma. Invited. Simposio Interanacional de Dermatologia Oncologica. Medellin, CO.
      17. 2015. Treatment of squamous cell carcinoma. Invited. Simposio Internacional de Dermatologia Oncologica. Medellin, CO.
      18. 2015. Pathogenesis of basal cell carcinoma. Invited. Simposio Internacional de Dermatologia Oncologica. Medellin, CO.
      19. 2015. Pathogenesis of squamous cell carcinoma. Invited. Simposio Internacional de Dermatologia Oncologica. Medellin, CO.
      20. 2012. Dermoscopy in dermatological practice. Invited. Gr. T Popa University of Medicine and Pharmacy. Iasi, RO.
      21. 2012. Introduction to Dermoscopy. Invited. Dermatological Spring Meeting. Iasi, RO.
      22. 2009. Malignant melanoma - a continuous challenge. Invited. University of Medicine and Pharmaceuticals. Iasi, RO.
      23. 2009. Management of Difficult-to-Treat Psoriasis Vulgaris. Invited. "Gh Nastase" Dermatology Symposium. Iasi, RO.
      24. 2009. In-situ photoimmunotherapy: a tumor directed treatment for stage IV melanoma with cutaneous metastases. Invited. SPIE Photonic West. San Jose, US.
      25. 2009. Psoriasis vulgaris, more than an inflammatory skin disorder - Oral Presentation, "Gh Nastase". Invited. "Gh Nastase" Dermatology Symposium. Iasi, RO.
      26. 1996. The Alcoholic Torsade de Pointes. Conference. The Alcoholic Torsade de Pointes. Iasi, RO.
      27. 1993. AIDS - Spreading and Particularities in Romania. Conference. National Symposium. Iasi, RO.
      28. 1993. AIDS - Neonatal Infection. Conference. National Symposium. Iasi, RO.
      29. 1992. Atrial Natriuretic Peptide - The Cardiac Endocrine Component. Conference. Annual Scientific Student Symposium. Iasi, RO.

      Formal Peers

      1. 2026. Kodas. Houston, Texas, US.
      2. 2026. Kodachromes. Houston, Texas, US.
      3. 2026. Board Review. Houston, Texas, US.
      4. 2026. Kodachromes. Houston, Texas, US.
      5. 2025. Kodachromes. Houston, Texas, US.
      6. 2025. Kodachromes. Houston, Texas, US.
      7. 2025. Kodachromes. Houston, Texas, US.
      8. 2025. Kodachromes. Houston, Texas, US.
      9. 2025. Kodachromes. Houston, Texas, US.
      10. 2024. Kodachromes. Houston, Texas, US.
      11. 2024. Kodachromes. Houston, Texas, US.
      12. 2023. Board Review. Houston, Texas, US.
      13. 2020. Kodachromes. Houston, Texas, US.
      14. 2016. Melanoma in the modern millennium: a dermatologist perspective. Invited. Omaha, NE, US.
      15. 2012. Dermoscopy Unknowns. Invited. Detroit, MI, US.
      16. 2012. "The Many Faces of Nevi and Melanoma". Invited. Detroit, MI, US.
      17. 2010. "Mimickers of Infectious Diseases in Cancer Patients:. Invited. Iasi, RO.
      18. 2010. "Dermal and Subcutaneous Tumors". Invited. Iasi, RO.
      Read More
      Less

      Grant & Contract Support

      Date: 2022 - 2027
      Title:Translating FLASH Radiobiological Insights to Cutaneous Malignancies,
      Funding Source:Medicaid
      Role:Co-I
      ID:FP00015770
      Date: 2015 - Present
      Title:Skin Cancer Medicaid Waiver Project
      Funding Source:Medicaid
      Role:Project Leader
      ID:1115 Waiver DSRIP
      Date: 2011 - 2015
      Title:Incidence of cutaneous squamous cell carcinoma and melanoma associated with prolonged use of voriconazole and posaconazole therapy at MD Anderson Cancer Center – 6-year experience
      Funding Source:Merck Co
      Role:PI
      ID:DR0866

      Selected Publications

      Peer-Reviewed Articles

      1. Lin J HE, Hegazy S, Aung PP, Nagarajan P, Muhaj F, Choksi AN, Ciurea AM, Nelson KC, Ivan D, Torres- Cabala CA, Prieto VG, Curry JL. Dermatologic toxicities associated with novel pan-RAS/RAF inhibitors. J Cutan Pathol, 2026. e-Pub 2026. PMID: 42244177.
      2. Alam, M, Kim, JY, Swary, JH, White, LE, Ciurea, AM, Dave, L, Brieva, J, Yoo, SS. Health utilities associated with nonmelanoma skin cancer. Journal of the American Academy of Dermatology 90(5):1042-1044, 2024. e-Pub 2024. PMID: 38215795.
      3. Baig, IT, Nguyen, QB, Hickson, MS, Ciurea, AM. Metastatic adenocarcinoma mimicking hidradenitis suppurativa. JAAD Case Reports 27:91-93, 2022. e-Pub 2022. PMID: 36039336.
      4. Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Nagarajan P, Curry JL, Ciurea AM, Rubin AI, Hwu WJ, Prieto VG, Aung PP. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma. Arch Pathol Lab Med 145(8):943-952, 2021. e-Pub 2021. PMID: 33290520.
      5. Clutter CA, Aneja S, Ivan D, Ciurea A, Silapunt S. Cutaneous Lesions of Multiple Myeloma of the Lower Extremity Masquerading as Squamous Cell Carcinoma. Cureus, 2020. e-Pub 2020.
      6. Ciurea SO, Hansrivijit P, Ciurea AM, Hymes S, Chen J, Champlin RE. Curative Potential of Hematopoietic Stem Cell Transplantation for Advanced Psoriasis. Am J Hematol 94(6):E176-E180, 2019. e-Pub 2019.
      7. Chen L, Parsons AM, Aria AB, Ciurea AM, Patel AB, Migden MR. Surgical Site Identification with Personal Digital Device: A Prospective Pilot Study. J Am Acad Dermatol 79(3):520-524, 2018. e-Pub 2018.
      8. Mudaliar K, Tetzlaff MT, Duvic M, Ciurea A, Curry JL. BRAF Inhibitor Therapy-Associated Melanocytic Lesions Lack the BRAF V600E Mutation and Show Increased Levels of Cyclin D1 Expression. Hum Pathol(50):79-89, 2016. e-Pub 2016.
      9. Yorio JT, Mays SR, Ciurea AM, Cohen PR, Wang WL, Hwu WJ, Gonzalez N, Richard JL, Kim KB. Case of Vemurafenib-Induced Sweet's Syndrome. J Dermatol 41(9):817-20, 2014. e-Pub 2014. PMID: 24617955.
      10. Vin H, Ching G, Ojeda SS, Adelmann CH, Chitsazzadeh V, Dwyer DW, Ma H, Ehrenreiter K, Baccarini M, Ruggieri R, Curry JL, Ciurea AM, Duvic M, Busaidy NL, Tannir NM, Tsai KY. Sorafenib Suppresses JNK-Dependent Apoptosis Through Inhibition of ZAK. Mol Cancer Ther 13(1):221-9, 2014. e-Pub 2014. PMID: 24170769.
      11. Farmakiotis D, Ciurea AM, Cahuayme-Zuniga L, Kontoyiannis DP. The Diagnostic Yield of Skin Biopsy in Patients with Leukemia and Suspected Infection. J Infect Dis 67(4):265-72, 2013. e-Pub 2013. PMID: 23769840.
      12. Mays R, Curry J, Kim K, Tsai K, Arora A, Khan F, Ramirez-Fort M, Ciurea A. Eruptive Squamous Cell Carcinomas After Vemurafenib Therapy. J Cutan Med Surg 17(6):419-22, 2013. e-Pub 2013.
      13. Rozas-Munoz E, Martinez Escala ME, Wang WL, Ciurea AM, Pujol RM, Prieto VG. A Slowly Growing Plaque on the Lower Back: Challenge. Am J Dermapathol 34(4):452-3, 2012. e-Pub 2012.
      14. Haitz K, Rady P, Nguyen H, Turing S, Ciurea AM. Merkel Cell Polyomavirus DNA Detection in a Patient with Merkel Cell Carcinoma and Multiple other Skin Cancers. Int J Dermatol 51(4):442-4, 2012. e-Pub 2012.
      15. St Pierre S, Rommel J, Ciurea A, West D, Laumann A. High Resolution, High Magnification Capillary Videomicroscopy Imaging as a Useful Adjunct in the Assessment of Pharmacological Intervention (Tadalafil) for Secondary Raynaud's Phenomenon Due To Scleroderma and Mixed Connective Tissue Diseases. J Am Acad Dermatol 62:AB11, 2010. e-Pub 2010.
      16. Ciurea A, Guitart J, Brieva J. Complete and Durable Response of Malignant Pyoderma to Tacrolimus in Combination with Dapsone and Prednisone. Arch Dermatol 146(1):102-103, 2010. e-Pub 2010.
      17. St Pierre SA, Rommel J, Ciurea A, Fife D, Yoo SS, Martini M, Kuzel TM, Wayne J, Rademaker A, West DP, Alam M. In Situ Photoimmunotherapy: A Surgery-and Limb-Sparing Approach to the Treatment of Cutaneous Metastases in Advanced Melanoma. Arch Dermatol 146(8):831-4, 2010. e-Pub 2010.
      18. Germani P, Wickless SC, Rosen S, Kuzel T, Ciurea A, Havey J, Guitart J. Applying the New TNM Classification System for Primary Cutaneous Lymphomas other than Mycosis Fungoides and Sezary Syndrome in Primary Cutaneous Marginal Zone Lymphoma. J Am Acad Dermatol 59(2):245-54, 2008. e-Pub 2008.
      19. Wickless S, Ciurea A, Gerami P, Guitart J. An Unusual Indolent Presentation of Intravascular B-cell Lymphoma in an Elderly Female. J Cut Pathol 35:91-9, 2008. e-Pub 2008.
      20. Krunic S, Ciurea A, Scheman A. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone. J Am Acad Dermatol 58(1):60-62, 2008. e-Pub 2008.
      21. Caruntu I, Ciurea A. Actinic Keratosis: A Histoenzymological Study. Morphol Embiol 15:132-135, 2000. e-Pub 2000.
      22. Caruntu I, Mihaila D, Ciurea A, Rascarachi G. Scoring Systems in the Histophthological Examination of the Hepatic Biopsy. Rev. Med. Chir. soc. Med. Nat 103:131-137, 1999. e-Pub 1999.
      23. Bostaca I, Ciurea S, Jescu A. The Heart: spectator or Participant in Neoplasia? Carcinoid Heart Disease. Romania Update 6:246-251, 1996. e-Pub 1996.
      24. Bostaca I, Ciurea A, de Pointes CSTAT. The Alcoholic Torsade de Pointes. Rev. Med. Chir. Soc. Med Nat III:86-88, 1996. e-Pub 1996.
      25. Bostaca S, Ciurea A, Jescu A, Florea M, Costachesu G. The Heart: Spectator or Participant in Neoplasia?. Med Chir. Soc. Med. Nat 6:53-61, 1995. e-Pub 1995.

      Invited Articles

      1. Diaz L, Ciurea A. Cutaneous and systemic adverse reactions to antibiotics. Dermatol Ther 25(1):12-22, 2012. e-Pub 2012.

      Review Articles

      1. Lin, PY, Shen, Y, Mathew, N, Hu, R, Huang, S, Queen, CM, West, CE, Ciurea, AM, Zouridakis, G. Synthetic Melanoma Image Generation and Evaluation Using Generative Adversarial Networks. Bioengineering 13(2), 2026. e-Pub 2026. PMID: 41749783.
      2. Liu, YA, Ciurea, AM, Aung, PP. A diagnostic approach to basaloid neoplasms of the skin. Diagnostic Histopathology 30(1):60-76, 2024. e-Pub 2024.

      Professional Educational Materials

      1. Ciurea AM. Q&A: Focus on Melanoma, 2013.
      2. Ciurea AM. Skin Cancer Screening: What Is It and Who Should Get It?, 2010.
      3. Halpern A, Ciurea AM, Berwick M, Geller A, Weinstock M, Hwu WJ, Federman D. The Jury Still Out on Wheather Skin Cancer Screening Saves Lives. HemOnc Today, 2009.

      Abstracts

      1. Diaz L, Bicknell L, Ciurea A, Kapil J. Cylindromatous carcinoma arising in a scalp cylindroma. American Academy of Dermatology Meeting, 2013. e-Pub 2013.
      2. Vin H, Ojeda SS, Ching G, Leung ML, Chitsazzadeh V, Dwyer DW, Adelmann CH, Restrepo M, Richards KN, Stewart LR, Du L, Ferguson SB, Chakravarti D, Ehrenreiter K, Baccarini M, Ruggieri R, Curry JL, Kim KB, Ciurea AM, Duvic M, Prieto VG, Ullrich SE, Dalby KN, Flores ER, Tsai KY. BRAF Inhibitors Suppress Apoptosis Through Off-Target Inhibition of JNK Signaling. Elife 2:e00969, 2012. e-Pub 2012. PMID: 24192036.
      3. Ciurea A, Prieto VG, Diaz L. Pigmented Paget's disease. American Academy of Dermatology Meeting, 2012. e-Pub 2012.
      4. Morgan L, Diaz L, Hymes S, Ciurea A. Dupuytren's contractures secondary to BRAF inhibitor. American Academy of Dermatology Meeting, 2012. e-Pub 2012.

      Book Chapters

      1. Ciurea AM. Vulvar Melanoma. In: Gynecologic Caring for the Female Cancer Patient. Cambridge, 2024.
      2. Ciurea, AM. Vulvar Melanoma, 383-393, 2024.
      3. Ciurea, AM, Margolin, K. Melanoma, 455-475, 2023.
      4. Ciurea A, Hymes S, Safdar A. Cutaneous Lesion that Mimic Infection in Organ Transplant Patients. In: Principles and Practice of Transplant Infectious Diseases. Springer, 397-416, 2019.
      5. Ciurea A. Epidemiology and clinical characteristics of melanoma. In: Genetics of Melanoma. Springer, 69-83, 2016.
      6. Ciurea A, Hymes S. Skin Conditions Mistaken for Infection in the Transplant Population. In: Principles and Practice of Transplant Infectious Diseases. Ed. Safdar A. Springer, 2014.
      7. Ciurea A, Margolin K. Malignant melanoma. In: Cancer Consult: Expertise for Clinical Practice. Wiley-Blackwell Health Sciences, 635, 2014.
      8. Hymes S, Chon S, Ciurea A. Cutaneous lesions that mimic infections. In: Principles and Practice of Cancer Infectious Diseases. Springer, 233-253, 2011.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 20, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top